Roth Capital Weighs in on Ontrak, Inc.’s Q3 2024 Earnings (NASDAQ:OTRK)

Ontrak, Inc. (NASDAQ:OTRK) – Stock analysts at Roth Capital cut their Q3 2024 earnings per share (EPS) estimates for shares of Ontrak in a research report issued to clients and investors on Thursday, October 10th. Roth Capital analyst J. Aschoff now forecasts that the company will post earnings of ($1.56) per share for the quarter, down from their previous forecast of ($1.50). The consensus estimate for Ontrak’s current full-year earnings is ($7.35) per share. Roth Capital also issued estimates for Ontrak’s Q4 2024 earnings at ($1.41) EPS, FY2024 earnings at ($7.39) EPS, FY2025 earnings at ($3.67) EPS, FY2026 earnings at ($0.36) EPS, FY2027 earnings at $0.06 EPS and FY2028 earnings at $0.10 EPS.

Ontrak (NASDAQ:OTRK) last announced its earnings results on Thursday, August 8th. The company reported ($0.19) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.10) by ($0.09). Ontrak had a negative net margin of 222.54% and a negative return on equity of 238.43%. The business had revenue of $2.45 million during the quarter, compared to the consensus estimate of $2.60 million. During the same period in the previous year, the firm posted ($1.84) EPS.

Separately, Roth Mkm cut their price target on Ontrak from $4.00 to $3.00 and set a “buy” rating for the company in a research note on Friday, August 9th.

Ontrak Stock Performance

Shares of NASDAQ:OTRK opened at $2.40 on Monday. Ontrak has a 12-month low of $1.81 and a 12-month high of $21.29. The company’s 50 day moving average price is $0.97 and its two-hundred day moving average price is $0.52. The firm has a market cap of $115.12 million, a PE ratio of -0.60 and a beta of 2.56. The company has a quick ratio of 3.64, a current ratio of 3.64 and a debt-to-equity ratio of 0.43.

About Ontrak

Ontrak, Inc operates as an artificial intelligence powered, telehealth-enabled, and virtualized healthcare company that provides in-person services to third-party payors in the United States. Its technology-enabled platform predicts people whose chronic disease will improve with behavior change, recommends effective care pathways that people are willing to follow, and engages and guides them to and through the care they need.